Physician
Internal Medicine
Dr. Jessica E. Haberer, MD
|
|
Give Review
Jessica Haberer practices Internal Medicine. She attended Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care Jessica E. Haberer, MD is also a published doctor. She has 45 publication published. The most recent publication is: Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis. She accepts all Medicare patients.
Publications
- Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.
- Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda.
- Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study.
- Comparing the Novel Method of Assessing PrEP Adherence/Exposure using Hair Samples to other Pharmacologic and Traditional Measures.
- Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda: A Qualitative Study.
- Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-...
- Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion.
- The Factor Structure and Presentation of Depression Among HIV-Positive Adults in Uganda.
- Declining Prevalence of Probable Depression Among Patients Presenting for Antiretroviral Therapy in Rural Uganda: The Role of Early Treatment Initiation.
- An intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda.
- HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention.
- Tobacco Use Among Adults Initiating Treatment for HIV Infection in Rural Uganda.
- The Dynamic Relationship Between Social Support and HIV-Related Stigma in Rural Uganda.
- The Kynurenine Pathway of Tryptophan Catabolism, CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART.
- Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda.
- Reversal of the Kynurenine Pathway of Tryptophan Catabolism May Improve Depression in ART-treated HIV-infected Ugandans.
- HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods.
- Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa.
- Preexposure prophylaxis for HIV prevention: where have we been and where are we going?
- Real-time adherence monitoring of antiretroviral therapy among hiv-infected adults and children in rural uganda.
- How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda.
- Internalized Stigma, Social Distance, and Disclosure of HIV Seropositivity in Rural Uganda.
- Furthering the reliable and valid measurement of mental health screening, diagnoses, treatment and outcomes through health information technology.
- Dissemination of Research Findings to Research Participants Living with HIV in Rural Uganda: Challenges and Rewards.
- GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda.
- Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda.
- Recent Trauma is Associated with Antiretroviral Failure and HIV Transmission Risk Behavior Among HIV-Positive Women and Female-Identified Transgenders.
- No Association Found Between Traditional Healer Use and Delayed Antiretroviral Initiation in Rural Uganda.
- Real-Time Electronic Adherence Monitoring is Feasible, Comparable to Unannounced Pill Counts, and Acceptable.
- Excellent Adherence to Antiretrovirals in HIV+ Zambian Children Is Compromised by Disrupted Routine, HIV Nondisclosure, and Paradoxical Income Effects.
- Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting.
- Real-time adherence monitoring for HIV antiretroviral therapy.
- Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes.
- Does Medicaid managed care affect access to care for the uninsured?
- Clinical problem-solving. One foot away.
- Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.
- The Chinese free antiretroviral treatment program: challenges and responses.
- Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.
- Caregiver Perceptions and Motivation for Disclosing or Concealing the Diagnosis of HIV Infection to Children Receiving HIV Care in Mbarara, Uganda: A Qualitative Study.
- Comparison of Self-Reported Alcohol Consumption to Phosphatidylethanol Measurement among HIV-Infected Patients Initiating Antiretroviral Treatment in Southwestern Uganda.
- Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China.
- Wireless fetal heart rate monitoring in inpatient full-term pregnant women: testing functionality and acceptability.
- Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.
- HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda.
Schools
Yale University School Of Medicine
University Of Ca San Francisco
Stanford University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
UCSF -
Yale University School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1417022831 | |
| NPPES Provider LastName | HABERER | |
| NPPES Provider FirstName | JESSICA | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 31.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417022831 |
| Last Name Of The Provider | HABERER |
| First Name Of The Provider | JESSICA |
| View All |
Similar Doctors
|
Dr. Towie Fong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eliza H. McCaw, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Philippe T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph G. Mallon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmed A. Salem, DO |
|
|
Dr. Alka M. Kanaya, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lisa M. Ochoa-Frongia, MD |
|
|
Dr. Jerold M. Lowenstein, MD |
|
|
David L. Hamel |